Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/29/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Samer Fakhri

Wrong Dr. Samer Fakhri?

PROFESSOR and VICE CHAIR, PROGRAM...

Phone: (713) ***-****  HQ Phone
The University of Texas Health Science Center at Houston
The University Of Texas Health Science Center At Houston 7000 Fannin Street
Houston , Texas 77030
United States

Company Description: One of a select group of US institutions designated as an Academic Health Center, The University of Texas Health Science Center at Houston (UTHealth), educates more...   more
Background

Employment History

  • Associate Professor and Program Director In the Department
    Otorhinolaryngology
  • Residency Program Director and Vice Chair In the Department
    Otorhinolaryngology
  • Surgeon
    Memorial Hermann-Texas Medical Center
  • Associate Professor and Program Director In the Department of Otorhinolaryngology
    Memorial Hermann-Texas Medical Center
  • Professor and Vice Chair
    Texas Medical Center
  • Associate Professor and Vice Chair
    Texas Medical Center
  • Professor and Vice Chair
    The University of Texas Medical School at Houston
  • Associate Professor and Residency Program Director
    The University of Texas Medical School at Houston
  • Rhinologist
    The University of Texas Medical School at Houston

Education

  • MD
  • medical degree
    McGill University
31 Total References
Web References
The Principal Investigator of the ...
www.hear4u.co.uk, 2 June 2015 [cached]
The Principal Investigator of the clinical trial is Samer Fakhri, M.D., surgeon at Memorial Hermann-Texas Medical Center and associate professor and program director in the Department of Otorhinolaryngology - Head & Neck Surgery at UTHealth. "Currently, the only treatment options for sensorineural hearing loss are hearing aids or cochlear implants," Dr. Fakhri said.
Dr. Samer ...
www.drseanboutros.com [cached]
Dr. Samer Fakhri
...
Dr. Samer Fakhri.
Dr. Samer Fakhri is an internationally renowned rhinologist who has been practicing in the Houston area for over 10 years. He is a founding member of the sinus center at Houston Plastics, Craniofacial and Sinus Surgery, a state of the art facility offering the highest level of expertise and personalized care to patients with nasal, sinus and skull base disorders. Patients and peers have recognized. Dr. Fakhri's skills and expertise as a sinus and skull base surgeon and have consistently named him to the local and national Top Doc lists including America's Best Doctors and the acclaimed Castle Connolly Top Doctors, an accomplishment achieved by only 2% of physicians. r. Fakhri holds leadership positions in healthcare institutions and specialty societies nationally and internationally.
The first of its kind in Houston and southeast Texas to offer comprehensive medical and surgical care for sinus and skull base disorders by a fellowship-trained rhinologist. In 2013, Dr. Fakhri received the University of Texas System Regents' Outstanding Teaching Award, the highest honor bestowed by the UT Board of Regents and one of the nation's most competitive awards for medical educators. He also received the medical school Dean's Teaching Excellence Award for 8 consecutive years. In late 2014 the president of UT Health awarded Dr. Fakhri the medal of excellence for his exemplary contributions to clinical care, education and research. During his tenure at UT, Dr. Fakhri served as Residency Program Director and Vice Chair in the department of Otorhinolaryngology-Head and Neck Surgery. He is credited with transforming the learning milieu and educational structure of the otolaryngology residency program and lifting it into a fully-accredited and highly sought-after training program. He contributes to the education of future otolaryngologists and has trained many residents and fellow surgeons. His expertise is widely recognized and he draws patients from across the globe.
Dr. Fakhri received his medical degree from McGill University in Montreal, Canada. He completed his residency training at McGill University Health Center and pursued fellowship training in rhinology at the Cleveland Clinic Foundation. He also completed a research fellowship in Allergy and Immunology at the Meakins-Christie Laboratories of McGill University. Dr. Fakhri is one of very few surgeons certified by both the American Board of Otolaryngology and the Royal College of Surgeons of Canada. He is a fellow of the American College of Surgeons, the Royal College of Surgeons of Canada, the American Academy of Otolaryngology-Head and Neck Surgery, and the American Rhinologic Society. He serves as a committee Chair at the American Rhinologic Society and contributes yearly instructional courses to the American Academy of Otolaryngology-Head and Neck Surgery. He is a frequently invited national and international panelist and speaker. Dr. Fakhri has published over 60 scientific articles and book chapters, including description of new minimally invasive surgical techniques to treat complex sinus conditions. Dr. Fakhri's areas of clinical interest include medical and surgical management of refractory chronic rhinosinusitis, sinus and nasal polyps, image-guided surgery, endoscopic lacrimal and orbital surgery, cerebrospinal fluid leak (CSF) repair, endoscopic removal of sinus and nasal tumors, and minimally invasive skull base surgery. Dr. Fakhri has a special interest in space medicine and managing sinus barotrauma and has been entrusted with the care of NASA astronauts, airline pilots and professional deep sea divers.
...
Dr. Fakhri's Care Philosophy
"There are a number of treatments ...
www.donmargolis.com, 1 July 2012 [cached]
"There are a number of treatments for hearing loss, but most of them rely on amplification of noises, not reversal of the hearing loss," said Dr. Samer Fakhri, associate professor and program director in the Department of Otorhinolaryngology at Memorial Hermann-Texas Medical Center, and principal investigator of the study.
...
Fakhri said it's still too early to determine whether the procedure benefitted Madeleine, or may be beneficial for other children.
...
"If there's any improvement, it should be detected within six months to a year," Fakhri said. "We can't determine from just one child if there's an overall benefit." If the study results show significant improvement overall among the collective children studied, children with acquired -- not genetic -- hearing loss, may be able to benefit from the procedure. "We do not recommend that stem cells at this point now should be a treatment modality for hearing loss," Fakhri said. Previous studies in mice suggest long-term hearing repair after stem cell infusion. Fakhri says it's likely that if the procedure works, children like Madeleine will have long-term restored hearing.
...
"The way the stem cells work is they support repair," said Fakhri.
...
Which is loss that has to do with the damage of the inner ear and nerve fibers that go to the brain," said Principal Investigator, Dr. Fakhri. Stem cells, saved from Madeline's own umbilical cord, were injected into her arm. "We expect that it will be safe. You are using your own blood stem cells as if it was your own transfusion," stated Dr. Fakhri.
...
"We can not expect what the results will be, but potentially it can repair and restore normal hearing," Fakhri said. Expensive stem cell treatments have gained negative attention for promising miraculous results.
First FDA-Approved Stem Cell Trial to Treat Hearing Loss Begins
www.stemcellsportal.com, 14 July 2012 [cached]
The yearlong trial is led by Samer Fakhri, MD, an internationally recognized rhinologist who is currently an associate professor and residency program director at The University of Texas Medical School at Houston.
The researchers are following 10 children, aged 6 weeks to 18 months old, who have sustained post-birth SNHL. Children who are deaf as a result of a genetic anomaly or syndrome are not eligible.
The patients are treated using stem cells from their own stored umbilical cord blood. "Currently, the only treatment options for sensorineural hearing loss are hearing aids or cochlear implants," Dr. Fakhri said.
Posted on Thursday, February 5th, 2009, ...
www.ut-ent.net, 24 May 2012 [cached]
Posted on Thursday, February 5th, 2009, by Samer Fakhri, MD, FACS, FRCS(C)
In the traditional classification of cerebrospinal fluid (CSF) leaks, spontaneous (or idiopathic) rhinorrhea is included under the "normal-pressure" category.
...
Samer Fakhri, MD, FACS, FRCS(C)
...
Samer Fakhri, MD, FACS, FRCS(C) Associate Professor 713-500-5414 | email | CV | Publications
Samer Fakhri, MD, is an internationally recognized rhinologist who is currently an Associate Professor and residency Program Director at The University of Texas Medical School at Houston. Dr. Fakhri received his medical degree from McGill University in Montreal, Canada. He completed his residency training at McGill University Health Center and pursued fellowship training in rhinology at the Cleveland Clinic Foundation. He also completed a research fellowship in Allergy and Immunology at the Meakins-Christie Laboratories of McGill University.
Dr. Fakhri has written 3 articles for the ORL Newsletters website.
Other People with the name "Fakhri":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304